Sabby Management’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-190,000
Closed -$602K 157
2017
Q2
$602K Sell
190,000
-10,000
-5% -$31.7K 0.04% 53
2017
Q1
$680K Buy
200,000
+100,000
+100% +$340K 0.04% 63
2016
Q4
$288K Buy
100,000
+50,000
+100% +$144K 0.02% 111
2016
Q3
$294K Buy
+50,000
New +$294K 0.01% 114
2015
Q1
Sell
-145,919
Closed -$2.4K 195
2014
Q4
$2.4K Sell
145,919
-114,081
-44% -$1.88K 0.08% 41
2014
Q3
$3.31K Buy
260,000
+107,006
+70% +$1.36K 0.13% 22
2014
Q2
$3.45M Buy
152,994
+101,484
+197% +$2.29M 0.15% 21
2014
Q1
$1.46M Buy
+51,510
New +$1.46M 0.08% 43